Thursday, 15 October 2026European Markets
ExploreSearch
ViaNews EU
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· July 21, 2026

Sagtec Global Limited Expands Strategic Partnership with Kinetic Seas to Launch Skilliks.AI Managed AI Memory Platform Across Southeast Asia

View original at globenewswire.com
Sagtec Global Limited Expands Strategic Partnership with Kinetic Seas to Launch Skilliks.AI Managed AI Memory Platform Across Southeast Asia KUALA LUMPUR, Malaysia, July 21, 2026 (GLOBE NEWSWIRE) -- Sagtec Global Limited (NASDAQ: SAGT) ("Sagtec" or the "Company"), a Nasdaq-listed technology solutions provider, today an…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • More than 80% of new databases provisioned on the Neon platform are now created automatically by AI agents rather than by human users.

    60% confidence

  • Memory is one of the most valuable assets an organization provides to its AI systems; MaluDB is designed to remain permanently open source, allowing organizations of all sizes to deploy enterprise-grade AI memory with governance and transparency, and the Sagtec partnership positions Kinetic Seas to support growing enterprise AI adoption across Southeast Asia.

    60% confidence

  • Southeast Asia's businesses are adopting AI rapidly, but many organizations remain focused on maintaining control over where their institutional knowledge resides; through this partnership, Sagtec can provide enterprise AI memory infrastructure built on open-source technology and supported by regional hosting capabilities, complementing its investment in sovereign AI infrastructure.

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com
Sagtec Global Limited Expands Strategic Partnership with Kinetic Seas to Launch Skilliks.AI Managed AI Memory Platform Across Southeast Asia — Source | Via News | ViaNews EU